BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 3523486)

  • 1. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
    Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids.
    Pratt CI; Wu SQ; Bhattacharya M; Kao C; Gilchrist KW; Reznikoff CA
    Cancer Genet Cytogenet; 1992 Apr; 59(2):180-90. PubMed ID: 1316224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes.
    Geiser AG; Anderson MJ; Stanbridge EJ
    Cancer Res; 1989 Mar; 49(6):1572-7. PubMed ID: 2647289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD; Allen HL; Kraynak AR; Bradley MO
    Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.
    Senger DR; Perruzzi CA; Ali IU
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5107-11. PubMed ID: 3293049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells.
    Craig RW; Sager R
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2062-6. PubMed ID: 3856884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression and re-expression of transformed phenotype in hybrids of HA-ras-1-transformed rat-1 cells and early-passage rat embryonic fibroblasts.
    Griegel S; Traub O; Willecke K; Schäfer R
    Int J Cancer; 1986 Nov; 38(5):697-705. PubMed ID: 3533793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.
    Ledwith BJ; Manam S; Kraynak AR; Nichols WW; Bradley MO
    Mol Cell Biol; 1990 Apr; 10(4):1545-55. PubMed ID: 1690847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
    Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
    Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenicity of human mesothelial cell line transfected with EJ-ras oncogene.
    Reddel RR; Malan-Shibley L; Gerwin BI; Metcalf RA; Harris CC
    J Natl Cancer Inst; 1989 Jun; 81(12):945-8. PubMed ID: 2733039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
    Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
    Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
    Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
    Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
    Braun L; Goyette M; Yaswen P; Thompson NL; Fausto N
    Cancer Res; 1987 Aug; 47(15):4116-24. PubMed ID: 2440558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene.
    Tarpley WG; Hopkins NK; Gorman RR
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3703-7. PubMed ID: 3012529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
    Schäfer R; Geisse S; Willecke K
    J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.